期刊文献+

SGLT2抑制剂治疗2型糖尿病的研究进展 被引量:14

下载PDF
导出
摘要 糖尿病患病率逐年增加,预计在未来的25年内患病人数会达5.9亿,其中2型糖尿病(type2 diabetes mellitus,T2DM)在成年糖尿病患者中占90%-95%,主要表现为高血糖、胰岛素分泌不足和胰岛素抵抗。血糖长时间增高,增加了患者大血管病变和微血管病变的危险性,前者主要包括冠心病,周围大血管粥样硬化和脑卒中,后者主要包括:糖尿病视网膜病变、
出处 《中国中西医结合肾病杂志》 2016年第1期82-85,共4页 Chinese Journal of Integrated Traditional and Western Nephrology
基金 国家自然科学基金-地区科学基金资助项目(No.#81160087) 内蒙古自然科学博士基金资助项目(No.2010BS1102) 内蒙古自治区科技计划项目-2015自治区应用技术研究与开发资金计划项目
  • 相关文献

参考文献45

  • 1谢席胜,艾娜,王宝福,夏梦迪,樊均明.糖尿病肾病流行病学研究进展[J].中国中西医结合肾病杂志,2013,14(10):937-940. 被引量:117
  • 2Del Prato S. Role of glucotoxicity and lipotoxicity in the pathophysiology of type 2 diabetes mellitus and emerging treatment strategies. Diabet Med ,2009 ,26 (12) : 1185 - 1192. 被引量:1
  • 3Pfister M, Whaley JM,Zhang L, et al. Inhibition of SGLT2: a novel strategy for treatment of type 2 diabetes mellitus. Clin Pharmacol Ther,2011,89 (4) :621 - 625. 被引量:1
  • 4Gerich JE. Role of the kidney in normal glucose homeostasis and in the hyperglyeaemia of diabetes mellitus: therapeutic implications. Diabet Med ,2010,27 ( 1 ) : 136 - 142. 被引量:1
  • 5Hediger MA, Rhoads DB. Molecular physiology of sodium - glucose cotransporters. Physiol Rev, 1994,74 (4) : 993 - 1026. 被引量:1
  • 6Wright EM, Hirayama BA, Loo DF. Active sugar transport in health and disease. J Intern Med ,2007,261 ( 1 ) :32 - 43. 被引量:1
  • 7Han S, Hagan DL, Taylor JR, et al. Dapagliflozin, a selective SGLT2 inhibitor,improves glucose homeostasis in normal and diabetic rats. Diabetes ,2008,57 (6) : 1723 - 1729. 被引量:1
  • 8Ferrannini E, Muscelli E, Frascerra S, et al. Metabolic response to sodiumglucose cotransporter 2 inhibition in type 2 diabetic patients. J Clin Invest,2014,124 (2) :499 - 508. 被引量:1
  • 9Merovci A, Solis - Hen'era C, Daniele G, et al. Dapagliflozin improves muscle insulin sensitivity but enhances endogenous glucose production. J Clin Invest,2014,124 (2) :509 - 514. 被引量:1
  • 10Polidori D, Mari A, Ferrannini E. Canagliflozin, a sodium glucose cotransporter 2 inhibitor, improves modelbased indices of beta cell function in patients with type 2 diabetes. Diabetologia, 2014,57(5) :891 -901. 被引量:1

二级参考文献41

  • 1周洁 ,向红丁 .北京市2型糖尿病患者糖尿病肾病流行病学分析[J].医学研究通讯,2004,33(6):10-12. 被引量:18
  • 2Whiting D,Guariguata L,Weil C,et al.IDF diabetes atlas:global estimates of the prevalence of diabetes for 2011 and 2030.Diabetes Res Clin Pract,2011,94(2):311-321. 被引量:1
  • 3Yang W,Lu J,Weng J,et al.Prevalence of diabetes among men and women in China.N Engl J Med,2010,362(12):1090-1101. 被引量:1
  • 4Centers for Disease Control and Prevention.National diabetes fact sheet:national Estimates and general in formation on diabetes and prediabetes in the United States,2011.USD epartment of Health and Human Services.Atlanta (GA):Centers for Disease Control and Prevention,2011. 被引量:1
  • 5Monesi L,Baviera M,Marzona I,et al.Prevalence,incidence and mortality of diagnosed diabetes:evidence from an Italian population-based study.Diabet Med,2012,29(3):385-392. 被引量:1
  • 6Deloitte AE.Two of a KinD (Kidneys in Diabetes):the burden of Diabetic kidney disease and the cost effectiveness of screening people with type 2 diabetes for chronic kidney disease.Kidney Health Australia.Melbourne (Victoria):Kidney Health Australia,2011. 被引量:1
  • 7United States Renal Data System.USRDS 2011 annual data report:atlas of Chronic kidney disease and end-stage renal disease in the United States.Bethesda (MD):National Institutes of Health.National Institute of Diabetes and Digestive and Kidney Diseases,2011. 被引量:1
  • 8Mollsten A,Svensson M,Waernbaum I,et al.Cumulative risk,age at onset,and sex-specific differences for developing end-stage renal disease in young patients with type 1 diabetes.A nationwide population-based cohort study.Diabetes,2010,59(7):1803-1088. 被引量:1
  • 9Finne P,Reunanen A,Stenman S,et al.Incidence of end-stage renal disease inpatients with type 1 diabetes.JAMA,2005,294(4):1782-1787. 被引量:1
  • 10Stadler M,Auinger M,Anderwald C,et al.Long-term mortality and incidence of renal dialysis and transplantation in type 1 diabetes mellitus.J Clin Endocrinal Metab,2006,91(10):3814-3820. 被引量:1

共引文献116

同被引文献105

引证文献14

二级引证文献111

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部